IntercontinentalExchange Inc’s bid for NYSE Euronext will now be reviewed by the European Commission to determine whether the deal is inline with EU antitrust law. The acquisition, offered at $8.2 billion, will place control of Europe’s second-largest derivatives market, Liffe, in ICE hands; it’s a move that will pit the company against rivals CME and Nasdaq OMX Group. Last year, ICE’s initial bid for NYSE failed. Earlier this year, the conglomerate requested that the European Commission review the deal as opposed to leaving the decision up to Portugal, Spain and Britain authorities.
Featured News
EU Trade Commissioner Warns Against Weakening Tech Rules Under US Pressure
Dec 15, 2025 by
CPI
South Korea’s Antitrust Chief Backs Stronger Rules for Digital Platforms
Dec 15, 2025 by
CPI
UK Treasury Eying New Rules for Crypto Firms
Dec 15, 2025 by
CPI
Publishers Win Class Certification in Antitrust Case Against Google Ad Exchange
Dec 15, 2025 by
CPI
FTC Moves to Block Henkel Deal for Liquid Nails Owner
Dec 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Acqui-hiring
Dec 11, 2025 by
CPI
Anticompetitive Effects of Acquihires: Labor and Product Markets
Dec 11, 2025 by
Heski Bar-Isaac, Justin Johnson & Volker Nocke
Acquihires In the Technology Sector: Antitrust Scrutiny Through the Lens of Economics
Dec 11, 2025 by
Juliette Caminade, Rebecca Kirk Fair, Zsolt Udvari & Jeanne Vellard Smith
M&A in the AI Era: Considerations for Acquihiring
Dec 11, 2025 by
Ingrid Vandenborre, Kenneth Schwartz, Christopher Barlow, Page Griffin, Michael Cardella, Stuart Levi, Taylor Votek, Benjamin Salzer, Lisa G. Liu & Liz Kraus
Lock Them Up, or Take No Prisoners? Merger Policy and Acquiring AI Talent: Human Rights and Other Inconvenient Facts
Dec 11, 2025 by
Simon R. Pritchard